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 Patient: Male, 73
 Final Diagnosis: Henoch-Schönlein purpura (HSP)
 Symptoms: Abdominal pain • bloating • blood in stool • nausea • vomiting
 Medication: —
 Clinical Procedure: EGD • colonoscopy • kidney biopsy • skin biopsy • arthrocentesis
 Specialty: Rheumatology
 Objective: Unknown ethiology
 Background: Henoch-Schönlein purpura (HSP), a small vessel vasculitis mediated by deposition of immune-complexes con-
taining IgA in the skin, gut, and glomeruli, often presents with abdominal pain, purpuric rash in the lower ex-
tremities and buttocks, joint pain, and hematuria. The disease most commonly targets children but can affect 
adults who tend to have a worse prognosis.
 Case Report: We discuss a case of HSP in an elderly Chinese male who presented with severe proximal bowel inflammation, 
vasculitic rash, and proteinuria; he was found to have positive stool rotavirus and giardia. He improved signif-
icantly with high dose steroids. We believe rotavirus may have been a triggering event in this patient. A brief 
review of the literature is also presented.
 Conclusions: This is the first case report describing a classic presentation of HSP in an adult following a rotavirus infection. 
HSP can cause significant morbidity and mortality in adult patients predominantly from progressive renal fail-
ure; therefore careful management and monitoring is important. GI infections seem to be a common trigger 
for HSP and this case report suggests that rotavirus may be part of the spectrum.
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Background
Henoch-Schönlein purpura (HSP) is a small vessel vasculitis 
mediated by deposition of immune-complexes containing IgA 
in the skin, gut, and glomeruli [1,2]. The disease constellation 
was first described in the 1800s in young boys with abdomi-
nal pain, vomiting, melena, joint pain, a purpuric rash, and he-
maturia [1,2]. William Osler believed the disease was an ana-
phylaxis reaction [1,2]. We now know that HSP is primarily a 
vasculitis involving deposition of IgA immune complexes [3]. 
However, the etiology of HSP is still uncertain; factors such 
as infection and hypersensitivity triggering the disease have 
been reported [3]. In adults, malignancy and drug exposure 
have been associated with HSP, which differs from drug-in-
duced hypersensitivity vasculitis as the latter lacks IgA deposi-
tion [4–6]. Gastrointestinal (GI) infections with campylobacter, 
helicobacter pylori, and other organisms have been reported 
to trigger HSP [7]. Our case suggests that rotavirus infection 
also may trigger the disease in adults.
Case Report
A 73-year-old Chinese man who was in his usual state of health 
presented with 2–3 days of progressively worsening lower ab-
dominal pain, dark stools, nausea, vomiting, and bloating. Prior 
to this, he had two weeks of constipation, which evolved into 
loose, dark stool one week prior to presentation. He travels 
frequently between China and the United States, but denied 
recent illness, tick or animal bites, or the addition of new med-
icines. His past medical history included chronic obstructive 
pulmonary disease, coronary artery disease, type II diabetes 
mellitus, and resection of a right parasagittal meningioma. On 
examination, he had a mildly distended abdomen with tender-
ness in the lower abdomen. Fecal occult blood test was posi-
tive, white blood cell count (WBC) was 14 k/mcL, and lactate 
was normal. Computerized tomography (CT) of the abdomen 
and pelvis showed markedly abnormal loops of proximal small 
bowel beginning in the distal duodenum and extending into 
the proximal jejunum manifested by extensive stranding and 
marked wall thickening (Figure 1A). He was managed conser-
vatively for suspected non-specific small bowel inflammation 
with improvement in leukocytosis and abdominal pain, and was 
discharged on empiric antibiotics, including levofloxacin and 
metronidazole for seven days and pantoprazole 40 mg daily.
He returned three days later with worsening and more diffuse 
abdominal pain, recurrent hematochezia, nausea and vomit-
ing. CT angiography of the abdomen and pelvis showed an in-
crease in the extent of small bowel inflammation proximally, 
involving more of the duodenum and jejunum without mes-
enteric ischemia (Figure 1B). A wireless capsule study was at-
tempted, but the capsule was retained in the stomach. Upon 
retrieval of the capsule with enteroscopy and esophagogastro-
duodenoscopy (EGD), he was found to have ulcers at the gas-
troesophageal (GE) junction, erythematous mucosa throughout 
the stomach, and extensive ulcerations in the second portion 
of the duodenum without evidence of Helicobacter pylori (H. 
pylori) or other signs of infection. Biopsies of the lesions re-
vealed severe active enteritis with ulceration and lamina pro-
pria hemorrhage, without H. pylori, cytomegalovirus (CMV) or 
herpes simplex viral inclusions. He developed ileus and was 
managed with nasogastric tube (NGT) suction with high gas-
tric outputs, and supportive total parenteral nutrition (TPN). 
A B
Figure 1.  Computerized tomography (CT). (A) Slice of CT of the abdomen and pelvis with contrast showing stranding around proximal 
small bowel (arrow) consistent with small bowel inflammation. (B) Coronal slice of a CT angiography (CTA) of the abdomen 
and pelvis showing proximal small bowel inflammation demonstrated by significant stranding around loops of bowel (arrow) 
and normal blood vessels with IV contrast.
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Testing for tuberculosis, Yersinia, CMV, human immunodeficien-
cy virus (HIV), Epstein-bar virus (EBV), hepatitis B virus (HBV), 
hepatitis C virus (HCV), H. pylori, salmonella, campylobacter, 
toxoplasma, shigella, ova and parasites, and clostridium diffi-
cile were all negative. Stool studies for giardia and rotavirus 
that were collected from the first admission were found to be 
positive during his second admission. He was treated with ni-
tazoxonide. Hematology was consulted for hypogammaglob-
ulinemia (IgG and IgM were low, IgA normal) and to rule out 
lymphoma, myeloproliferative disorders or solid tumors. Blood 
smear, bone marrow biopsy, flow cytometry, and various mu-
tation testing were all unremarkable. Repeat EGD with colo-
noscopy showed slightly improved duodenal ulcers, and a tu-
bular adenoma and hyperplastic polyps, respectively.
Three days after his second admission, he developed left knee 
pain and a purpuric rash in his palms, soles, wrists, and an-
kles. Skin biopsy disclosed a leukocytoclastic vasculitis more 
consistent with a primary vasculitis rather than a drug rash. 
Immunofluorescence performed after antigen retrieval of for-
malin fixed paraffin embedded tissue sections disclosed gran-
ular IgA deposition in the dermal vessels (Figure 2). He was 
started on 40 mg daily IV Solu-Medrol with gradual improve-
ment of his symptoms, including abdominal pain, rash, and he-
matochezia. Left knee joint arthrocentesis showed clear fluid 
with 85 WBCs, no crystals or bacteria, consistent with non-in-
flammatory arthritis. Laboratory studies revealed ANA 1: 40, 
ANCA negative, C3 66 mg/dL (reference range: 88–252 mg/dL), 
C4 13 mg/dL (reference range: 12–72 mg/dL), erythrocyte sedi-
mentation rate (ESR) 55 mm/hour and C-reactive protein (CRP), 
72.2 mg/dL, with normalization of inflammatory markers with 
steroid treatment.
His urine analysis (UA) showed 2+ protein with a protein cre-
atinine ratio (UPC) of 1.7 g/g, 15 red blood cell (RBC) and 18 
WBC with normal serum creatinine of 0.7 mg/dL. UA done sev-
eral months prior to this event was normal. He was diagnosed 
with HSP given the abdominal, renal, skin, and joint findings. 
Despite being treated with steroids, he developed facial and 
lower extremity edema with a rising creatinine to 1.2 mg/dL 
and worsening proteinuria, now 2.9g/24 hours, prompting re-
nal biopsy (Figure 3).
The renal biopsy contained a total of 60 glomeruli of which 11 
were globally sclerotic. And 20% of the glomeruli had active nec-
rotizing and crescentic lesions and 10% had endocapillary hyper-
cellularity without mesangial hypercellularity. Immunofluorescence 
disclosed mesangial staining for IgA with lesser staining for IgM, 
C3, fibrinogen, and both light chains, and mesangial deposits 
were identified ultrastructurally consistent with HSP.
He was managed with higher doses of IV steroids and angio-
tensin converting enzyme inhibitor (ACEI) for three weeks, 
with stabilization of renal function, and he was discharged 
with a prolonged oral steroid taper. One month later, he had 
improved but with persistent hematuria (115 to 37 RBC) and 
proteinuria (UPC 3+ to 2+). Screening colonoscopy with biop-
sy revealed rare CMV inclusions, which were treated with two 
weeks of IV ganciclovir. He completed the steroid taper after 
two months and has continued to do well.
A B
Figure 2.  Skin biopsy. (A) Dermal small vessel vasculitis showing fibrin, neutrophils, and karyorrhectic debris within and surrounding 
vessel walls with extravasated erythrocytes (H & E ×400). (B) Granular deposition of IgA within dermal vessels (following 
antigen retrieval on formalin fixed paraffin embedded tissue, ×400).
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Discussion
Henoch-Schönlein’s purpura (HSP) is a small vessel vasculitis 
mediated by deposition of immune-complexes containing IgA 
in the skin, gut, and glomeruli [1,2]. Histologically, patients 
affected with HSP have polymorphonuclear leukocyte infiltra-
tion of small vessel walls with leukocytoclasia and immuno-
fluorescence showing IgA deposits [1–3]. The clinical features 
of HSP include palpable purpura, arthritis, gastrointestinal (GI) 
involvement, and glomerulonephritis [1–3]. GI involvement is 
very common affecting 50%-80% of patients and can often pre-
cede purpura [8]. Nephritis is a serious complication of HSP, 
which infrequently may result in end stage renal failure [8–11].
HSP mainly affects children with an annual incidence esti-
mated to be 15 cases/100,000 per year compared to 1.3 cas-
es/100,000 per year in adults [4]. Although the incidence of 
HSP is lower in adults, studies suggest adults have more renal 
disease compared to children [5,6,9–11]. Uppal et al. compared 
adults and children with HSP and found that renal involvement 
was more frequent and severe in adults (90% in adults versus 
52.4% in children). Adults had more diarrhea and leukocyto-
sis, required more aggressive therapy and had longer hospital 
stays [9-11]. Outcome was also slightly worse in adults with 
complete recovery in 90% compared to 98.8% in children [9–
11]. Therefore, age at onset is considered an important factor 
for disease manifestation, severity, and outcome [9–11]. Risk 
factors for progression to end-stage renal disease (ESRD) fol-
lowing HSP in children include older age, abdominal symp-
toms, low factor XIII activity, and persisting purpura [9–11]. 
However, prognostic factors in adults are less clear and there 
are no convincing and carefully done studies examining risk 
factors for developing ESRD following HSP in adults.
There are different criteria for HSP developed by the American 
College of Rheumatology (ACR) and European League Against 
Rheumatism (EULAR); but both require palpable purpura, ab-
dominal pain and evidence of small vessel vasculitis on biop-
sy [12,13]. The diagnostic criteria do not include serologic find-
ings but IgA level is often elevated [14,15]. The serum IgA was 
normal in our patient, which is unusual. However, Fahima et al. 
reported a case of HSP in a middle-aged man who presented 
with enteritis and had normal IgA levels [16]. Yang et al. found 
IgA anti-endothelial cell antibodies (AECA) positively correlat-
ed with HSP and could stimulate IL-8 production in endothe-
lial cells [14,15]. It is possible that IgA levels could be normal 
in HSP but undergo alteration of the IgA profile. Furthermore, 
our patient had low IgG and IgM but normal IgA levels, sug-
gesting a relatively increased IgA level in the setting of low 
baseline total immunoglobulin levels.
Complement levels are usually normal in HSP, C3 was low 
and C4 was borderline normal in our patient. However, there 
are reports of post-infectious development of HSP associated 
with hypocomplementemia [18]. Lin et al. identified 53 chil-
dren with HSP and usually transiently decreased C3 and/or 
C4 levels, and found this did not impact the extent of nephri-
tis or outcome; however, this cohort had elevated ASO titers 
suggesting a prior triggering infection [19]. Yan-xiang et al. 
suggested that complement activation by immunoglobulin in 
patients with HSP plays an important role in renal injury [17]. 
Future studies are needed to investigate whether C3 and C4 
A B C
Figure 3.  Kidney biopsy. (A) Glomerulus showing a segmental necrotizing and crescentic lesion, and mild mesangial widening but 
without mesangial hypercellularity (Jones methenamine silver ×240). (B) Glomerulus staining for IgA in mesangial regions 
(×240). (C) Electron micrograph with mesangial electron dense deposits (arrows) often beneath the paramesangial basement 
membrane (original magnification ×10,000).
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levels have any prognostic value in terms of renal involvement 
in adults with HSP [17–19].
Adults are also more likely than children to have secondary 
causes of HSP [6]. HSP has been associated with hypersensi-
tivity to drugs [20–27]. Cancer, blunt trauma, monoclonal IgA 
gammopathy, Wiskott-Aldrich syndrome carrier status, and 
chronic alcoholic liver disease also have been reported to cause 
HSP [28–32]. Lahita described a 22 year old female with re-
current episodes of HSP since puberty occurring monthly with 
menstruation, who achieved remission during pregnancy, and 
in a dose responsive manner when prescribed birth control pills 
containing progesterone and estradiol, suggesting a patholog-
ic role of male sex hormones [33].
Rotavirus is a non-enveloped virus first described in 1973 by 
Bishop and colleagues and is responsible for half of all cas-
es of diarrhea requiring hospital admission amongst children 
younger than 2 years [34,35]. In contrast, most non-bacteri-
al causes of adult gastroenteritis are related to Norwalk-like 
viruses [34]. Rotavirus outbreaks typically occur in the win-
ter/spring seasons [35]. Our patient presented in the spring, 
which is consistent with epidemiological data of peak rota-
virus infections. There are seven distinct groups of rotavirus 
with groups A, B, and C reported as human pathogens, with 
group A, the main detected pathogen worldwide [34]. Adults 
tend to shed less virus, which may be undetectable by most 
routine assays [34]. The mechanism by which rotavirus induc-
es diarrhea is still poorly understood and most infections are 
self-limited. The presentation of adult acute rotavirus infec-
tion is highly variable and includes diarrhea, fever, headache, 
malaise or cramping [34]. Interestingly, asymptomatic infec-
tions may occur in up to 40% of infected adults [34]. Past in-
fections with rotavirus do not prevent reinfections, as the ini-
tial antibody response to infection is serotype specific [34]. 
However, rotavirus reinfection is associated with fewer symp-
toms and an antibody response [34]. Our patient presented 
in the spring, the peak time for rotavirus infection, and was 
asymptomatic as many adults are. It also is possible that our 
patient was a carrier for rotavirus without having rotaviral 
disease. Champsaur et al. in 1984 studied 179 children and 
discovered that viral carriage, without infection or serologic 
response, was as high as 27% [36]. Since GI symptoms often 
precede the development of purpura and nephritis, it is rea-
sonable to suspect that HSP in children may be related to as-
ymptomatic rotavirus infection. Although rotavirus infection 
is a relatively rare in adults, it also may be a contributor to 
HSP in this population.
Giardia also has been reported to be associated with HSP [7]. 
It was unlikely the sole cause of HSP in our patient given lack 
of diarrhea or history to suggest chronic giardiasis. However, 
it is possible that giardia may have been a predisposing factor 
with concomitant or superimposed rotavirus infection trigger-
ing active HSP. Additionally, our patient was found to have cy-
tomegalovirus (CMV) on follow-up, which may be reactivation 
or de novo infection. Ninomiya et al. described a 61year-old 
male treated for HSP who was later found to have CMV as a 
complication of the patient’s immunosuppressed state [37]. 
Murakami et al. described a 14-year-old boy who suffered from 
reactivation of latent CMV after diagnosis and treatment for 
HSP [38]. These are similar to our case, in which CMV was iden-
tified following immunosuppression with high dose steroids. 
D’Alessandro et al. suggested that CMV vasculitides may mimic 
HSP, rather than being sequelae of steroid treatment or tempo-
rary immunosuppression [39]. It is unlikely that CMV vasculitis 
was the cause of our patient’s presentation as multiple endo-
scopic exams, GI biopsies, and serologic tests were negative for 
CMV at presentation, and rare CMV inclusions were found only 
after steroid treatment. Nonetheless, viral vasculitides should 
remain in the differential while evaluating a patient with HSP.
Herein we describe a 73-year-old Asian gentleman who pre-
sented with GI symptoms and was found to have rotavirus and 
giardia infections, who later developed a cutaneous vasculitis 
and glomerulonephritis diagnostic for HSP. While rotavirus is 
a common cause of diarrhea in children, infection in adults is 
rare in the developed world [35]. Various pathogens have been 
associated with HSP, including bacteria, viruses, and protozoa; 
to date, there have been no reported cases or studies associ-
ating rotavirus infections with HSP [7,40,41]. However, a link 
between rotavirus and HSP may be inferred from reports of 
disease following rotavirus vaccination. Felicetti et al. found 
that 15.5% of adults and up to 34.5% of children developed a 
vasculitis following vaccination, with HSP the most frequent 
lesion, most often associated with meningococcal, measles, 
and HPV vaccines [42]. Currently, universal rotavirus vaccina-
tion is considered safe and effective, and is recommended in 
infants [43]. The seroresponse rate to rotavirus vaccine is most 
importantly determined by the anti-rotavirus IgA seroconver-
sion rate, emphasizing the importance of IgA production in the 
immunologic response to rotavirus infection [44,45]. Vaccine 
side effects include intussusception, gastroenteritis and vas-
culitis, with vasculitides associated with rotavirus vaccines 
almost entirely reported in infants less than one year of age, 
with 91.5% of these the Kawasaki disease type [46]. It is pos-
sible that this rise in IgA titer is associated with post-vaccina-
tion HSP, likely in predisposed patients.
In addition to infection, certain genetic variations have been 
associated with susceptibility to and pathogenesis of HSP. A 
role for genetic predisposition to HSP was suggested by ep-
idemiologic differences across different ethnic groups, and 
familial aggregation of HSP [47]. Major histocompatibility 
complex (MHC) and non-MHC genes, proinflammatory cyto-
kines genes, endothelial nitric oxide synthase (eNOS), matrix 
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metalloproteinase (MMPs), MEFV gene, and many others have 
been implicated as possible predisposing or protective factors 
in the pathogenesis of HSP [48–62]; however, most of these 
studies were limited to the pediatric population and focused 
on specific ethnic groups. An et al. studied the association 
between C1GALT1 polymorphisms, a gene coding an enzyme 
important for kidney homeostasis, and the risk of HSP in a 
Chinese population [49]. They found that certain single nucle-
otide polymorphisms (SNPs) and genotypes of C1GALT1 were 
associated with significantly higher risk of developing HSP [49]. 
Lopez-Majias et al. found that certain HLA alleles were asso-
ciated with susceptibility for HSP while others have a protec-
tive effect [50,51]. Ding et al. recently studied polymorphisms 
in heat-shock protein 70-2 (HSP70-2) and tumor necrosis fac-
tor alpha (TNF-a) and found the HSP70-2 (+1267A/G) and 
TNF-a (+308G/A) gene polymorphisms were associated with 
HSP in a Chinese cohort of children [53]. HSP70-2 polymor-
phisms previously were associated with certain rheumatic dis-
eases such as ankylosing spondylitis (AS) and systemic lupus 
erythematosis (SLE) [55,56]. Chen et al. showed that certain 
genotypes of PAX2, an essential nuclear transcription factor 
in the development of human embryonic kidney, may be as-
sociated with higher risk of renal involvement in children with 
HSP [60]. Mahsa et al. found association between carriage of 
IL-1 receptor antagonist allele 2 and allele A of the IL-8 gene 
and increased susceptibility to renal involvement [61,62]. It is 
therefore likely that under certain environmental influences 
or following an infection, individuals with a particular geno-
type would be predisposed to developing HSP.
Conclusions
In conclusion, this patient was found to have giardia and rota-
virus infections with diarrhea in association with active HSP. 
This is the first case report describing a classic presentation of 
HSP in an adult following a rotavirus infection. HSP can cause 
significant morbidity and mortality in adult patients predom-
inantly from progressive renal failure, therefore careful man-
agement and monitoring is important. GI infections appear to 
be a common trigger for HSP and this case report suggests 
that rotavirus may be part of this spectrum.
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